Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma
-
Published:2024-06
Issue:
Volume:
Page:
-
ISSN:1590-8658
-
Container-title:Digestive and Liver Disease
-
language:en
-
Short-container-title:Digestive and Liver Disease
Author:
Eleonora Alimenti,
Lynch Erica NicolaORCID,
Natola Leonardo AntonioORCID,
Massimo IavaroneORCID
Reference25 articles.
1. HCC special interest group of the Italian association for the study of the liver. personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept;Vitale;Lancet Oncol,2023
2. Validation of a risk estimation of tumor recurrence after transplant (RETREAT) score for hepatocellular carcinoma recurrence after liver transplant;Mehta;JAMA Oncol,2017
3. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996
4. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial;Mazzaferro;Lancet Oncol,2020
5. Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]